Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire Arrived EquityMultiple

TOOLS

Top Smart Score Stocks

Research Tools

Most Visited Websites

Daily Feeds

Daily Analyst Ratings

Daily Insider Trading Tracker

Calendars

Economic Indicators

Economic Indicators Center

Inflation Rate

Unemployment Rate

Federal Funds Rate

Class Actions

Calculators

Dividend Calculator

Dividend Yield Calculator

Options Profit Calculator

Dollar Cost Averaging

Technical Analysis Screener

Dividend Center

Best Dividend Stocks

Popular

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

AZN Stock Latest News

The FlyAstraZeneca’s Datroway approved in U.S. for HER2-negative breast cancer patients

8h ago

AZN

PremiumMarket News

Novo Nordisk’s (NYSE:NVO) Ozempic and Wegovy Lined Up for Medicare Drug Price Negotiations

17h ago

AZN

BMY

PremiumThe Fly

Ozempic, Xtandi among next 15 drugs selected for U.S. price talks

18h ago

AZN

BHC

PremiumThe Fly

AstraZeneca price target raised to 13,100 GBp from 12,600 GBp at Guggenheim

19h ago

AZN

PremiumThe Fly

AstraZeneca’s Calquence combination approved in U.S.

19h ago

AZN

PremiumThe FlyDrugmakers to push Trump to pause price negotiations, Bloomberg reports

4d ago

AZN

BMY

Ionis unveils pipeline plan for 2025, expects 4 independent product launches

Premium

The Fly

Ionis unveils pipeline plan for 2025, expects 4 independent product launches

4d ago

AZN

IONS

Compugen initiated with an Outperform at Oppenheimer

Premium

The Fly

Compugen initiated with an Outperform at Oppenheimer

5d ago

AZN

CGEN

PremiumThe Fly

AstraZeneca, Daiichi Sankyo datopotamab deruxtecan BLA granted priority review

5d ago

AZN

PremiumMarket News

Johnson & Johnson (NYSE:JNJ) Jumps to Year’s High on Lung Cancer Drug Success

10d ago

AZN

JNJ

PremiumThe Fly

AstraZeneca call volume above normal and directionally bullish

12d ago

AZN

PremiumThe Fly

AstraZeneca call volume above normal and directionally bullish

15d ago

AZN

PremiumThe FlyHutchmed announces NDA acceptance in China, payment from AstraZeneca

16d ago

AZN

HCM

Premium

Class Action

Levi & Korsinsky LLP Announces the Filing of a Securities Class Action on Behalf of AstraZeneca PLC(AZN) Shareholders

22d ago

AZN

AstraZeneca Withdraws Lung Cancer Drug Application in EU

Premium

Company Announcements

AstraZeneca Withdraws Lung Cancer Drug Application in EU

23d ago

AZN

PremiumThe Fly

Achilles Therapeutics sells technology assets to AstraZeneca for $12M

25d ago

AZN

ACHL

PremiumThe Fly

AstraZeneca, Daiichi Sankyo have voluntarily withdrawn a Dato-DXd MAA in EU

25d ago

AZN

PremiumThe Fly

AstraZeneca’s Tagrisso approved in EU for certain types of NSCLC

26d ago

AZN

PremiumMarket News

3 Best Stocks to Buy Now, 12/12/2024, According to Top Analysts

1M ago

AZN

EFX

PremiumThe FlyAstraZeneca says 87.5% of Lynparza-treated patients alive at six years in trial

1M ago

AZN

MRK

AstraZeneca, Daiichi Sankyo announce BTD for datopotamab deruxtecan

Premium

The Fly

AstraZeneca, Daiichi Sankyo announce BTD for datopotamab deruxtecan

1M ago

AZN

AstraZeneca reports ‘positive’ results from AMPLIFY Phase 3 trial

Premium

The Fly

AstraZeneca reports ‘positive’ results from AMPLIFY Phase 3 trial

1M ago

AZN

AZN Stock Latest News

Trending

Indices

Stocks

ETFs